Almudena Rodriguez‐Gutierrez

A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors

Michael A. Samuels, Johan Falkenius, Voichita Bar‐Ad et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 66 citations · Full text

Medicine, Oncology, Pharmacology +15

A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

Paul B. Romesser, Jaume Capdevila, Rocio García‐Carbonero et al. · Clinical Cancer Research · 2023 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors

Bradford A. Perez, Raid Aljumaily, Thomas U. Marron et al. · ESMO Open · 2024 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study

Jean Bourhis, Lisa Licitra, Barbara Burtness et al. · Journal of Clinical Oncology · 2025 · 15 citations · Full text

Medicine, Oncology, Radiation Oncology +12